In clinical TB models, the virulent Peking strain exhibits an enhanced capacity to suppress lung protective immunity by inducing elevated levels of type I interferon, thereby leading to reduced TNF-α levels and diminished T cell activation when compared with strains from other lineages (19). The gene discussed is TNF; the disease is tuberculosis.